Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
about
Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitationsFunctional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancersDCE-MRI: a review and applications in veterinary oncologyUncertainty in MR tracer kinetic parameters and water exchange rates estimated from T1-weighted dynamic contrast enhanced MRIIntratumor mapping of intracellular water lifetime: metabolic images of breast cancer?Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data.Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison studyTumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.Parametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma.Non-invasive imaging of angiogenesis in head and neck squamous cell carcinomaMolecular imaging in cancer treatment.The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Applications of molecular imaging.Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesTechniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancerIn Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRIDCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage.Evaluation of Head and Neck Tumors with Functional MR Imaging.Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerCurrent oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neckRole of quantitative magnetic resonance imaging parameters in the evaluation of treatment response in malignant tumors.The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma.Treatment monitoring of paranasal sinus tumors by magnetic resonance imaging.Clinical imaging of tumor angiogenesis.The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?.Models and methods for analyzing DCE-MRI: a review.Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.Simultaneous measurement of T1 /B1 and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.Separation of benign and malignant breast lesions using dynamic contrast enhanced MRI in a biopsy cohort.Neuroradiology back to the future: head and neck imaging.
P2860
Q26740275-EA79975F-5A53-417D-B097-1AE102D5596BQ28075983-C1680D0E-CD78-4F2A-8B84-A9CA2680D330Q28704234-0D765E44-CA0C-4C3A-B35A-C792FE8A875AQ30665072-D9FB5AB6-8DCA-4B81-BEE3-643813B16305Q30814598-34A4CE75-F622-4DAB-B600-672A1AF564DEQ30996246-365FD7ED-6AD6-42A4-8909-FE3223045A07Q31106171-7B80CDF5-6B84-4AF9-ABBA-B532ED65E736Q33793870-D71DCFCF-0D88-41C2-8518-64D445245E29Q33933009-1E08106C-A4C8-4072-B7CD-BB1AC2934FC1Q34029591-BA4B1B46-03FF-4131-B0CA-EC2C30B0DF38Q34496670-D7D36B31-092A-4610-847A-71EDB64D4836Q34635573-54A7FD9E-AC8C-4755-A2CF-0ED6A939FE16Q34757933-D677CF47-0E76-4EF6-87B2-E698DC35FC58Q34951384-4D8EC02D-323E-4078-8256-BD5DC7CFC2F4Q35082412-2CA6F56C-F6E4-480D-B52F-75ECF9D77082Q35202162-CA27F53F-3A27-47B9-AABF-DD0AAB7652CFQ35223964-0B1DFCED-3630-4242-BC9D-A655072ACB44Q35596205-32876837-DE9D-496D-B230-4285CCA7220BQ35744865-D5A8A8A2-17BE-4C26-9DF5-CCB9BDF9FD2CQ35866622-D1B3CA08-CE41-4971-933F-6619D1F2C202Q36235448-BAD39D3E-4D97-4C7A-8546-FF46763C47DBQ36330208-8BDBBFF1-AA82-4898-9E52-D58BD0A29023Q36515722-A7BAACAF-21AD-4F25-8935-6FB6A939E4F3Q36529838-47488701-B141-4934-86C5-53C7D508C853Q36547400-6D5ECB79-6F4B-499F-83B7-7BF9E972F9AAQ36801476-D99D96B2-FE62-4D90-8A4F-97CDBAC370CFQ37328698-B1AB9EF6-AA1A-4042-94B4-6ACCCD5A0286Q37442942-BB40879D-E3B7-430F-B1BA-C2ACF1F2E052Q37780361-5E0B8564-F133-4BA9-B07B-B378445ACA70Q38059503-CEAE7F4D-2609-436F-8B60-74F3B5DD0221Q38073089-B51B556A-9A42-4A4C-8A09-E839F7F413A4Q38282639-82C6A714-E192-4C2D-BCA4-E2A51E40225AQ38597048-CBC0560B-AB33-445F-8BC9-5366E8C96B8FQ38764089-F9481738-2041-4B7E-8233-6EE3FA03FABFQ38830809-95EF19BF-BFAB-4A07-9286-09E25C0DC252Q38836743-83C2B6DC-97BE-4D29-AE64-252AB1B4DC70Q38866273-8450366D-2FC8-4D64-8D73-393909CC6D85Q39159557-D85D6469-24BA-48D6-9E5E-3F5A00C8A5D9Q39263802-9BEF8EF9-9677-4B9E-8281-D695F33BCF33Q39536766-C16B4C0F-FD30-4DA4-A1E7-6977F58DBD5E
P2860
Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prediction of response to chem ...... contrast-enhanced MR imaging.
@en
Prediction of response to chem ...... contrast-enhanced MR imaging.
@nl
type
label
Prediction of response to chem ...... contrast-enhanced MR imaging.
@en
Prediction of response to chem ...... contrast-enhanced MR imaging.
@nl
prefLabel
Prediction of response to chem ...... contrast-enhanced MR imaging.
@en
Prediction of response to chem ...... contrast-enhanced MR imaging.
@nl
P2093
P2860
P356
P1476
Prediction of response to chem ...... contrast-enhanced MR imaging.
@en
P2093
G Weinstein
L A Loevner
P2860
P304
P356
10.3174/AJNR.A1817
P577
2009-10-01T00:00:00Z